These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1742861)

  • 1. Prophylaxis and treatment of newborn endotoxic shock with anti-lipid A monoclonal antibodies.
    Goto M; Zeller WP; Hurley RM; Jong JS; Lee CH
    Circ Shock; 1991 Sep; 35(1):60-4. PubMed ID: 1742861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-lipid A monoclonal antibodies and anti-LPS antiserum effects on limulus activity of LPS.
    Goto M; Yoshioka T; Lichtenberg R; Lee CH; Zeller WP
    Res Commun Mol Pathol Pharmacol; 1994 Dec; 86(3):341-6. PubMed ID: 7712110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-lipid A monoclonal antibodies alter human endothelial cell ICAM-1 expression in vitro.
    Renzi PM; Lee CH
    Shock; 1995 May; 3(5):329-36. PubMed ID: 7648333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diltiazem treatment of endotoxic shock in suckling rats.
    Goto M; Zeller WP; Lichtenberg RC; Hurley RM
    J Lab Clin Med; 1992 Sep; 120(3):465-70. PubMed ID: 1517692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the immune response to lipopolysaccharide. Existence of an interspecies cross-reactive idiotype associated with anti-lipid A antibodies.
    Su SD; Ward MM; Apicella MA; Ward RE
    J Immunol; 1990 Nov; 145(9):2994-3001. PubMed ID: 2212671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage treatment in suckling rat endotoxic shock.
    Goto M; Lichtenberg RC; Gottschalk ME; Anderson CL; Mathews HL; Zeller WP
    Circ Shock; 1993 Dec; 41(4):256-60. PubMed ID: 8143352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic immunotherapy in newborn rat endotoxicosis.
    Goto M; Zeller WP; Mathews H; Hurley RM
    Circ Shock; 1989 Aug; 28(4):357-67. PubMed ID: 2673571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of a monoclonal antibody against lipid A in endotoxic shock.
    Mead PS; Guo JP; Lefer AM; Pierce S; Palladino M
    Methods Find Exp Clin Pharmacol; 1994; 16(6):405-12. PubMed ID: 7837831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of monoclonal antibodies to lipid A for the correction of the hemodynamic disorders in endotoxemia].
    Rumiantsev AG; Kasatkin VN; Blokhin BM; Golubykh VL; Borovikov DV; Vlasik TN; Kanaeva ES; Kalantarov GF
    Gematol Transfuziol; 1993 Jan; 38(1):31-3. PubMed ID: 8020702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anti-lipid A monoclonal antibody (E5) on microcirculatory function during lipopolysaccharide shock.
    Schwartz RW; Arden WA; Pofahl W; Derbin M; Oremus R; Greenberg RN; Gross DR
    J Surg Res; 1993 May; 54(5):474-9. PubMed ID: 8361172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytokines and septic shock. New perspectives on its treatment].
    Zamora Madaria E
    An Med Interna; 1993 Dec; 10(12):573-5. PubMed ID: 8049320
    [No Abstract]   [Full Text] [Related]  

  • 13. Dexamethasone and indomethacin treatment during endotoxicosis in the suckling rat.
    Goto M; Zeller WP; Hurley RM
    Circ Shock; 1990 Oct; 32(2):113-22. PubMed ID: 2253315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic treatment of endotoxic shock with monophosphoryl lipid A in newborn rats.
    Wy CA; Goto M; Young RI; Myers TF; Muraskas J
    Biol Neonate; 2000 Mar; 77(3):191-5. PubMed ID: 10729723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis.
    Opal SM; Cross AS; Sadoff JC; Collins HH; Kelly NM; Victor GH; Palardy JE; Bodmer MW
    J Clin Invest; 1991 Sep; 88(3):885-90. PubMed ID: 1885775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological intervention in endotoxin shock.
    Ziegler EJ
    Prog Clin Biol Res; 1988; 272():319-25. PubMed ID: 3293079
    [No Abstract]   [Full Text] [Related]  

  • 17. [Introduction of immunotherapeutic agents in clinical practice; current status concerning anti-endotoxin antibody HA-1A in the control of sepsis].
    van Deventer SJ; van der Linden CJ; Roord JJ; Schellekens H; Schellekens JF
    Ned Tijdschr Geneeskd; 1993 Feb; 137(7):334-6. PubMed ID: 8437630
    [No Abstract]   [Full Text] [Related]  

  • 18. [Septic shock in newborn infants].
    Mancilla-Ramírez J
    Bol Med Hosp Infant Mex; 1992 Nov; 49(11):766-76. PubMed ID: 1466777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of IgM and IgA-enriched immunoglobulins in the treatment of severe sepsis and septic shock. Clinical experience.
    Berlot G; Dimastromatteo G
    Minerva Anestesiol; 2004 Oct; 70(10):739-43; 743-5. PubMed ID: 15516885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.